Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,148
datasets available to search
ShareScore release 0.9.0
Dataset results
2,148 results for “HER2”
Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer
ClinicalTrials.gov study NCT03820830. IPD Sharing: NO. Countries: 6. Publications: 9.
Efficacy and Safety of Pyrotinib in Patients With HER2 Mutation Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT02535507. IPD Sharing: Not stated. Countries: 1. Publications: 2.
PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY
ClinicalTrials.gov study NCT03423199. IPD Sharing: Not stated. Countries: 4. Publications: 1.
A Study of TAS0728 in Patients With Solid Tumors With HER2 or HER3 Abnormalities
ClinicalTrials.gov study NCT03410927. IPD Sharing: Not stated. Countries: 4. Publications: 2.
A Phase II Study of Neoadjuvant Trastuzumab+Docetaxel+NPLD+/-Bevacizumab in Her2-pos. Early Breast Cancer
ClinicalTrials.gov study NCT01367028. IPD Sharing: Not stated. Countries: 1. Publications: 87.
A Study of Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+Metastatic Breast Cancer Who Have Prior Received Anthracyclin, Taxane or Trastuzumab
ClinicalTrials.gov study NCT02422199. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
ClinicalTrials.gov study NCT05372614. IPD Sharing: YES. Countries: 1. Publications: 1.
A First-in-human Study of Multiple Doses of BB-1701 in Subjects With Locally Advanced/Metastatic HER2 Expressing Solid Tumors
ClinicalTrials.gov study NCT04257110. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers
ClinicalTrials.gov study NCT02892123. IPD Sharing: NO. Countries: 3. Publications: 1.
Human HER2-targeted Macrophages Therapy for HER2-positive Advanced Gastric Cancer With Peritoneal Metastases
ClinicalTrials.gov study NCT06224738. IPD Sharing: NO. Countries: 1. Publications: 2.
Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2
ClinicalTrials.gov study NCT00004935. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Positron Emission Tomography (PET) Imaging With Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness
ClinicalTrials.gov study NCT03321045. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Weekly Gemcitabine and Trastuzumab in the Treatment of Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT00193063. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Clinical Efficacy of Pucotenlimab Combined With Lenvatinib and SOX Versus SOX Alone in Patients With HER2-Negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
ClinicalTrials.gov study NCT07356466. IPD Sharing: NO. Countries: 1. Publications: 21.
Research for the Molecular Imaging of the HER2 Targeting Tracer
ClinicalTrials.gov study NCT04547309. IPD Sharing: NO. Countries: 1. Publications: 4.
Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer
ClinicalTrials.gov study NCT06253494. IPD Sharing: YES. Countries: 1. Publications: 3.
Dual-targeting HER2 and PD-L1 CAR-T for Solid Tumors
ClinicalTrials.gov study NCT04684459. IPD Sharing: Not stated. Countries: 1. Publications: 1.
GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases
ClinicalTrials.gov study NCT03765983. IPD Sharing: YES. Countries: 1. Publications: 0.
Disitamab Vedotin Plus Lenvatinib and PD-1 Inhibitors for Treating HER2-positive Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT07159217. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study to Evaluate Lumretuzumab in Combination With Pertuzumab and Paclitaxel in Participants With Metastatic Breast Cancer Expressing Human Epidermal Growth Factor Receptor (HER) 3 and HER2 Protein
ClinicalTrials.gov study NCT01918254. IPD Sharing: Not stated. Countries: 4. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.